CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- 4 Shares withheld for taxes CEO gave up 2,363 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CHINA OPERATIONS gave up 17,395 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 20,840 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 782 shares (to pay taxes)
- 4 Open-market buy Chief Medical Officer bought 22,123 shares at $1.17 ($25,884)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 18,979 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CHINA OPERATIONS gave up 19,289 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 2,255 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CEO gave up 20,840 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CEO gave up 782 shares (to pay taxes)
- 4 Open-market buy CEO bought 50,000 shares at $1.91 ($95,470)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 21,930 shares (to pay taxes)
Page 3 of 38 · 760 filings